Hyundai Pharmaceutical Market Cap

Hyundai Pharmaceutical has a market cap or net worth of 205.37 billion as of May 19, 2026. Its market cap has increased by 117.60% in one year.

Market Cap

205.37B

Enterprise Value

n/a

Revenue

108.14B

Ranking

n/a

PE Ratio

122.97

Stock Price

7,250.00

Market Cap Chart

Since August 30, 1995, Hyundai Pharmaceutical's market cap has increased from 28.77B to 205.37B, an increase of 613.71%. That is a compound annual growth rate of 6.60%.

Market Cap History

Date	Market Cap	% Change
May 19, 2026	205.37B	-12.91%
Dec 30, 2025	235.81B	137.66%
Dec 30, 2024	99.22B	-12.77%
Dec 28, 2023	113.76B	-14.20%
Dec 29, 2022	132.58B	-19.22%
Dec 30, 2021	164.12B	-22.93%
Dec 30, 2020	Upgrade Pro	Upgrade Pro
Dec 30, 2019	Upgrade Pro	Upgrade Pro
Dec 28, 2018	Upgrade Pro	Upgrade Pro
Dec 28, 2017	Upgrade Pro	Upgrade Pro
Dec 29, 2016	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Boditech Med	227.25B
BNC KOREA	223.31B
REYON Pharmaceutical	222.48B
Chong Kun Dang Holdings	218.51B
CMG Pharmaceutical	214.37B
Whan In Pharm	207.21B
Jeil Pharmaceutical Co.,Ltd	202.25B
Daewon Pharmaceutical	199.97B

Market Cap Rankings